From: Assessing a modified-AJCC TNM staging system in the New South Wales Cancer Registry, Australia
Tumour group | Pre-RD-staging a | Post-RD-staging b | |||||
---|---|---|---|---|---|---|---|
AJCC-SG staged cases (n,%) | DoS staged cases (n,%) | Total number of cases in NSWCR | AJCC-SG staged cases (n,%) | DoS staged cases (n,%) | RD-staged cases (n,%) | Total number of cases eligible for RD-staging | |
Melanoma | 367 (8.78%) | 4019 (96.19%) | 4179 | 3804 (97.79%) | 3791 (97.48%) | 3801 (98.68%) | 3890 |
Prostate | 1737 (22.53%) | 5449 (71.58%) | 7710 | 6946 (96.17%) | 5147 (72.16%) | 6919 (98.62%) | 7223 |
Colorectal | 2620 (50.94%) | 4726 (92.07%) | 5143 | 4217 (88.41%) | 4460 (93.7%) | 4244 (91.29%) | 4770 |
Breast | 3688 (53.13%) | 6450 (92.93%) | 5155 | 4457 (92.89%) | 4549 (94.81%) | 4518 (96.66%) | 4798 |
Lung | 2078 (55.05%) | 3180 (83.91%) | 3794 | 2778 (77.34%) | 3072 (85%) | 2957 (87.23%) | 3618 |
Total | 10,490 (37.8%) | 23,824 (86.15%) | 25,981 | 22,202 (91.47%) | 21,019 (86.88%) | 22,439 (95.16%) | 24,299 |